Nobligan Retard 200 mg Noruega - noruec - Statens legemiddelverk

nobligan retard 200 mg

grünenthal gmbh - tramadolhydroklorid - depottablett - 200 mg

Trampalgin 37.5 mg / 325 mg Noruega - noruec - Statens legemiddelverk

trampalgin 37.5 mg / 325 mg

karo pharma as - tramadolhydroklorid / paracetamol - tablett - 37.5 mg / 325 mg

Escitalopram Mylan 10 mg Noruega - noruec - Statens legemiddelverk

escitalopram mylan 10 mg

mylan ab - escitalopramoksalat - tablett, filmdrasjert - 10 mg

Escitalopram Mylan 5 mg Noruega - noruec - Statens legemiddelverk

escitalopram mylan 5 mg

mylan ab - escitalopramoksalat - tablett, filmdrasjert - 5 mg

Escitalopram Mylan 20 mg Noruega - noruec - Statens legemiddelverk

escitalopram mylan 20 mg

mylan ab - escitalopramoksalat - tablett, filmdrasjert - 20 mg

Tambocor 100 mg Noruega - noruec - Statens legemiddelverk

tambocor 100 mg

viatris as - flekainidacetat - tablett - 100 mg

Tambocor Retard 200 mg Noruega - noruec - Statens legemiddelverk

tambocor retard 200 mg

viatris as - flekainidacetat - depotkapsel, hard - 200 mg

Tambocor 10 mg/ ml Noruega - noruec - Statens legemiddelverk

tambocor 10 mg/ ml

viatris as - flekainidacetat - injeksjonsvæske, oppløsning - 10 mg/ ml

Fintepla Unió Europea - noruec - EMA (European Medicines Agency)

fintepla

ucb pharma s.a.   - fenfluramine hydrochloride - epilepsies, myoclonic - antiepileptics, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.

Metylfenidat Medical Valley 18 mg Noruega - noruec - Statens legemiddelverk

metylfenidat medical valley 18 mg

medical valley invest ab - metylfenidathydroklorid - depottablett - 18 mg